e-Profile Login and ID Quick Search
European Health Care Providers Collaborate on Plan to Reduce Counterfeit Drug Dangers
The World Health Professions Alliance (WHPA) Prague Call to Action (PDF), a plan developed to reduce the impact of counterfeit drugs on patients and the public in central Europe and beyond, was endorsed by participants of a recent WHPA-sponsored workshop in Prague, Czech Republic. As explained in a WHPA press release (PDF), workshop participants – including international health care association directors, patient groups, and other industry stakeholders – discussed a comprehensive regional action plan based on four key strategies:
- Increasing the capacity of health care providers to educate the public
- Fostering regional cooperation initiatives
- Strengthening collaborative practice when managing patients
- Improving collaboration with health and enforcement authorities plus other key stakeholders.
The WHPA plan stresses that counterfeit drugs and counterfeit medical products are an alarming public health threat in central and south eastern European countries, and that when such products enter the legitimate supply chain they may “cause disease, disability and death to patients and healthy individuals around the world.”
